Form 4: Atlassian Co-CEO Michael Cannon-Brookes Executes Stock Sales Under 10b5-1 Trading Plan
SEC Form 4
Michael Cannon-Brookes, Co-CEO of Atlassian, reports the sale of Class A Common Stock through a series of transactions executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Cannon-Brookes, Co-CEO and Co-Founder of Atlassian, filed a Form 4 detailing changes in beneficial ownership.
- The report indicates that Cannon-Brookes sold Class A Common Stock on June 20, 2024, through multiple transactions.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on February 8, 2024.
- The sales were conducted at varying prices, with weighted-average prices reported for each set of transactions.
- The shares were held indirectly by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.
- Following the reported transactions, the number of shares beneficially owned indirectly by the trust decreased.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock sales under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
Sales by insiders are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1. These plans allow insiders to diversify their holdings while avoiding concerns about trading on material non-public information.
Comparison to Industry Standards
- Comparing insider sales activity to peers like Microsoft (MSFT), Adobe (ADBE), and Salesforce (CRM) shows that such transactions are a normal part of executive compensation and portfolio management.
- The scale of these sales is relatively small compared to the overall market capitalization of Atlassian and the typical trading volumes of its stock.
Stakeholder Impact
- The stock sales may have a minor impact on shareholders due to the slight dilution of shares.
- The impact on employees, customers, suppliers, and creditors is expected to be negligible.
Key Dates
| Date | Description |
|---|---|
| 02/08/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 06/20/2024 | Date of stock sale transactions |
| 06/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.